Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

DPT Completes Site Transfer and Receives FDA Approval to Manufacture Sterile Ointment

By Pharmaceutical Processing | December 8, 2010

DPT Laboratories, Ltd., a pharmaceutical contract
development and manufacturing organization, announced today that it received
FDA approval to manufacture commercial supplies of a leading sterile ointment
for wound care at its Center
of Excellence for Sterile
& Specialty Products in Lakewood,
N.J. Beginning this month,
Healthpoint will ship commercial lots of Collagenase SANTYL(R) Ointment
produced at DPT’s Lakewood
facility to its North American customers.

“We are very excited to achieve this important
milestone,” stated Travis E. Baugh, President and Chief Operating Officer
of Healthpoint.

“DPT and Healthpoint have had a long and mutually
beneficial relationship over the years, with DPT having been our preferred manufacturing
partner on a variety of products. The recent FDA approval of DPT’s Lakewood facility to
produce Collagenase SANTYL(R) Ointment allows Healthpoint to immediately double
its production capacity, thereby helping assure continuous, uninterrupted
supply for this important therapeutic agent.” Building on its reputation
as the industry leader for semi-solids and liquids, DPT’s Sterile & Specialty
Products center focuses on aseptic production of sterile dosage forms to
include small-volume parenterals, ophthalmic preparations, preservative-free
nasal sprays and sterile ointments.

The SANTYL(R) approval is the third commercial approval for the
Lakewood
facility since launching its full-scale sterile operation in early 2010. The
first approval was for a new sterile product that is launching in North America
and Europe; the second approval was for manufacturing
an existing product used for ophthalmic therapy. The company will begin
manufacturing small-volume parenterals and additional ophthalmic preparations
in early 2011 and expects to successfully complete several site transfers and
new product launches over the next 24 months.

“Our team in Lakewood
has executed this project from the ground up and demonstrated a solid
commitment to best practices in developing and commercializing sterile
products,” said Gene Ciolfi, DPT General Manager for Sterile &
Specialty Products. “Receiving FDA approval to manufacture this leading
wound care product underscores our commitment to serve the healthcare community
and improve patient health and quality of life.”  

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards